uMotif Expands Leadership Team to Support Growth in US and European Markets

LONDON and BOSTON, July 19, 2022 /PRNewswire/ — uMotif, creator of the patient-centric eCOA/ePRO and engagement platform that transforms the reliability of patient-reported, site-based endpoint data, has appointed three new leaders . The expanded management team will drive uMotif’s ambitious growth strategy in the US and European markets, including guiding the future development and adoption of uMotif’s intuitive and engaging retention technology.

  • Gary PerrotFinancial directoris a Fellow of the Institute of Chartered Accountants of England and Wales, and worked in the life sciences industry for two decades. He joins uMotif after serving as vice president of finance for the global health sciences business unit at Oracle. Gary will use his experience to guide and manage uMotif’s financial operations as the business grows.
  • Kristine Klingerdelivery manager, has over 25 years of experience building Enterprise Program Management Offices (EPMOs) with international regulated industries including biotechnology, medical devices, electronic data entry for pharmaceuticals and devices medical, health insurance and counseling services. Kristine will use this experience to help the growing number of uMotif customers use the platform to transform their clinical and real-world study designs and accelerate their patient engagement strategies.
  • Elaine MaynardMarketing Vice President, has over 20 years of experience in a wide range of marketing, strategy and business development roles for cloud-based software companies. She led the marketing departments of Phase Forward, a pioneer in electronic clinical trial data collection, and the global business unit of Oracle Health Sciences. She will now apply her skills to raising awareness and expanding the use of uMotif’s patient-centric software.

In addition, Don Butler joined uMotif in October 2021 as chief revenue officer, bringing 18 years of clinical trial innovation experience to the company. Don previously held senior sales positions at Verana Health, Outcome Health, Medidata Solutions, Oracle Health Sciences and Siebel Life Sciences. At uMotif, he works closely with the sales, marketing, finance and product teams to help the organization identify and realize new revenue opportunities.

The nominations come just months after uMotif secured a $25.5 million investment of a fund managed by New Yorkinvestment company, Athyrium Capital Management, LP, and is part of the organization’s ambitious expansion strategy.

Steve RosenberguMotif CEOsaid: “Recent years have seen an increase in the popularity of decentralized clinical trials (DCTs) as well as a greatly increased demand for post-marketing studies and real-world evidence. This is accompanied by a growing demand for remote data collection solutions, above all ePRO and eCOA. However, many are far from easy to use, placing an additional burden on participants, leading to reduced patient engagement which contributes to poor retention.

“The new members of our leadership team understand that the key to success is working in partnership with patients and sponsors to offer modern and intuitive servicescloud-native systems people want to use, without ever compromising data quality. By delivering high rates of data capture, patient retention, data quality and speed of delivery, the technology helps sponsors and CROs conduct more efficient and faster trials. and real-life studies . In one study, for example, uMotif’s software engaged participants so effectively that data entry times were reduced by 33%.

“uMotif has worked with many of the world’s largest pharma, biotech and CRO companies, including AstraZeneca, Abbvie, and Syneos, resulting in unique insights and data capture rates over 90%. With With this new team in place, we now have everything we need to continue on this exciting trajectory.”

About uMotif

uMotif’s mission is to put patients at the center of clinical research. Built with patients for patients, uMotif’s cloud-native eClinical patient-first platform powers fully decentralized clinical, real-world and post-marketing research. By engaging patients and healthcare professionals, uMotif is trusted by global pharmaceutical companies, biotechs, CROs and academic institutions to capture large volumes of eCOA/ePRO, symptom and wearable device data.

For press contacts:

Elaine Maynard: [email protected]

SOURCE uDesign

Comments are closed.